Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine.
作者信息
Giuffrida Gaetano, Condorelli Annalisa, Di Giorgio Mary Ann, Markovic Uros, Sciortino Roberta, Nicolosi Daniela, Di Raimondo Francesco
机构信息
Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania.
Division of Hematology, AOU "Policlinico G. Rodolico-San Marco", Via Santa Sofia 78, 95124 Catania, Italy; Postgraduate School of Hematology, University of Catania.
出版信息
Haematologica. 2022 Apr 1;107(4):1008-1010. doi: 10.3324/haematol.2021.279535.
Abstract
摘要
相似文献
1
Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine.
Haematologica. 2022 Apr 1;107(4):1008-1010. doi: 10.3324/haematol.2021.279535.
2
COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents.
Pediatr Blood Cancer. 2022 Jun;69(6):e29681. doi: 10.1002/pbc.29681. Epub 2022 Apr 4.
3
Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine.
Ann Hematol. 2022 Mar;101(3):717-719. doi: 10.1007/s00277-021-04584-y. Epub 2021 Jul 26.
4
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
Thromb Res. 2022 Jun;214:115-121. doi: 10.1016/j.thromres.2022.04.020. Epub 2022 May 2.
5
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.
J Thromb Haemost. 2021 Sep;19(9):2314-2317. doi: 10.1111/jth.15420. Epub 2021 Jul 7.
6
Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine.
Int J Hematol. 2021 Nov;114(5):626-629. doi: 10.1007/s12185-021-03190-y. Epub 2021 Jul 15.
7
Refractory immune TTP following Pfizer-BioNTech COVID-19 vaccine successfully salvaged with caplacizumab.
J Thromb Haemost. 2022 Jul;20(7):1696-1698. doi: 10.1111/jth.15751. Epub 2022 May 18.
8
Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine: Case Report and Literature Review.
Lab Med. 2022 Nov 3;53(6):e145-e148. doi: 10.1093/labmed/lmac016.
9
Comment on: COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents.
Pediatr Blood Cancer. 2022 Dec;69(12):e29749. doi: 10.1002/pbc.29749. Epub 2022 Apr 29.
10
Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination.
Am J Emerg Med. 2021 Nov;49:441.e3-441.e4. doi: 10.1016/j.ajem.2021.05.001. Epub 2021 May 4.
引用本文的文献
1
A Systematic Review of Vascular Injuries: A Review of Petechiae, Purpura, and Ecchymosis in Critical Situations Following COVID-19 Vaccination.
Health Sci Rep. 2025 Mar 12;8(3):e70503. doi: 10.1002/hsr2.70503. eCollection 2025 Mar.
2
Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac.
Front Med. 2024 Aug;18(4):744-751. doi: 10.1007/s11684-023-1054-2. Epub 2024 Jul 3.
3
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) - Time to think beyond thrombosis with thrombocytopenia syndrome (TTS).
Thromb Update. 2022 May;7:100104. doi: 10.1016/j.tru.2022.100104. Epub 2022 Apr 18.
4
Thrombotic Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccination in a Patient With Multiple Myeloma: Case Report and Literature Review.
Cureus. 2023 Oct 10;15(10):e46784. doi: 10.7759/cureus.46784. eCollection 2023 Oct.
5
Recurrence of Thrombotic Thrombocytopenic Purpura After Vaccination with mRNA-1273 COVID-19 vaccine.
J Community Hosp Intern Med Perspect. 2022 Jul 4;12(4):80-84. doi: 10.55729/2000-9666.1073. eCollection 2022.
6
Acquired Thrombotic Thrombocytopenic Purpura Following Inactivated COVID-19 Vaccines: Two Case Reports and a Short Literature Review.
Vaccines (Basel). 2022 Jun 24;10(7):1012. doi: 10.3390/vaccines10071012.
7
COVID-19 Vaccines and Autoimmune Hematologic Disorders.
Vaccines (Basel). 2022 Jun 16;10(6):961. doi: 10.3390/vaccines10060961.
8
Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature.
Front Med (Lausanne). 2022 May 17;9:890661. doi: 10.3389/fmed.2022.890661. eCollection 2022.
9
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
Thromb Res. 2022 Jun;214:115-121. doi: 10.1016/j.thromres.2022.04.020. Epub 2022 May 2.
10
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study.
Haematologica. 2022 Nov 1;107(11):2661-2666. doi: 10.3324/haematol.2022.280702.
本文引用的文献
1
Immune Thrombocytopenic Purpura Cases Following COVID-19 Vaccination.
Mediterr J Hematol Infect Dis. 2021 Mar 1;13(1):e2021047. doi: 10.4084/MJHID.2021.047. eCollection 2021.
2
Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome.
J Clin Endocrinol Metab. 2021 Aug 18;106(9):2600-2605. doi: 10.1210/clinem/dgab373.
3
Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination.
Am J Emerg Med. 2021 Nov;49:441.e3-441.e4. doi: 10.1016/j.ajem.2021.05.001. Epub 2021 May 4.
4
Immune-Mediated Disease Flares or New-Onset Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination.
Vaccines (Basel). 2021 Apr 29;9(5):435. doi: 10.3390/vaccines9050435.
5
Immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
Br J Haematol. 2021 Aug;194(3):547-549. doi: 10.1111/bjh.17508. Epub 2021 May 2.
6
Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine.
Transfus Apher Sci. 2021 Aug;60(4):103145. doi: 10.1016/j.transci.2021.103145. Epub 2021 Apr 16.
7
SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.
N Engl J Med. 2021 Jun 10;384(23):2254-2256. doi: 10.1056/NEJMe2106315. Epub 2021 Apr 16.
8
Severe, Refractory Immune Thrombocytopenia Occurring After SARS-CoV-2 Vaccine.
J Blood Med. 2021 Apr 6;12:221-224. doi: 10.2147/JBM.S307047. eCollection 2021.
9
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management.
J Clin Med. 2021 Feb 2;10(3):536. doi: 10.3390/jcm10030536.
10
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
Zotero 插件